Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in P450 research.

J L Raucy1, S W Allen

  • 1La Jolla Institute for Molecular Medicine, San Diego, CA 92121, USA. jraucy@ljimm.org

The Pharmacogenomics Journal
|March 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spectroscopic confirmation of a mature galaxy cluster at a redshift of 2.

Nature·2020
Same author

Pharmacokinetics of the transdermal fentanyl patch in a feline ovariohysterectomy model.

Veterinary anaesthesia and analgesia·2017
Same author

Turbulent heating in galaxy clusters brightest in X-rays.

Nature·2014
Same author

The Effect of X-rays on Living Tissue.

The Journal of medical research·2009
Same author

Distribution of plutonium particles in the lungs of Mayak workers.

Radiation protection dosimetry·2003
Same author

Postductal origin of the left carotid, left subclavian, and aberrant retroesophageal right innominate arteries in truncus arteriosus with interrupted aortic arch.

Pediatric cardiology·2003
Same journal

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.

The pharmacogenomics journal·2026
Same journal

Beyond the 'Pregnancy Black Box': a global roadmap for artificial intelligence-driven pharmacogenomics in maternal-neonatal health.

The pharmacogenomics journal·2026
Same journal

The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke.

The pharmacogenomics journal·2026
Same journal

Development and validation of an open data model for pharmacogenetics to enable semantic interoperability in clinical practice.

The pharmacogenomics journal·2026
Same journal

Finasteride, pharmacogenomics, and suicide risk: a public health concern.

The pharmacogenomics journal·2026
Same journal

Cost-effectiveness of genome-guided statin treatment for hypercholesterolemia.

The pharmacogenomics journal·2026
See all related articles

Recent advancements in cytochrome P450 (CYP450) research, including structural determination and genetic discoveries, are improving drug development and predicting patient responses. These findings promise safer and more effective therapies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Genetics

Background:

  • Cytochrome P450 (CYP450) enzymes are crucial for metabolizing diverse chemicals.
  • Significant research progress has been made in understanding CYP450 functions.
  • Current knowledge is increasingly applied to drug development and clinical practice.

Purpose of the Study:

  • To highlight recent breakthroughs in P450 research.
  • To emphasize the impact of these advancements on drug efficacy and safety.
  • To discuss the implications for personalized medicine and drug interaction prediction.

Main Methods:

  • Crystallographic determination of mammalian P450 enzyme structure.
  • Identification of novel P450 alleles using advanced technologies.

Related Experiment Videos

  • Construction of P450 null and humanized transgenic animal models.

    • Main Results:

    • Structural insights enhance understanding of P450 structure-activity relationships.
    • New P450 alleles explain interindividual variations in drug response.
    • Animal models elucidate the role of P450 enzymes in drug toxicity.

    Conclusions:

    • Recent P450 research advancements are crucial for predicting drug interactions and individual responses.
    • These developments will lead to safer and more effective drug therapies.
    • Further research in P450 enzymology and genetics is vital for optimizing pharmaceutical treatments.